EbookNetworking
🔍 Search Books
Home
›
Publishers
›
Washington Information Source, Inc.
Books by Publisher: Washington Information Source, Inc.
36 books
📄 Lite AMP version
Full site ›
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medtronic Neurological draws 9-item 483 for design input, production process issues.(MEDICAL DEVICES): An article from: Inspection Monitor
Unavailable
9.95
View Details ›
OTC drug maker cited for failure to investigate deviations, provide GMP training.(Human Drugs): An article from: Validation Times
Unavailable
9.95
View Details ›
USP workshop examines the role of bioassays in drug development.(Bioassays): An article from: Validation Times
Carrie Nathans
9.95
View Details ›
Wyeth vaccine facility faulted for quality, production and laboratory system controls.(BIOLOGICS): An article from: Inspection Monitor
Unavailable
9.95
View Details ›
Contract Medical Manufacturing Oxford, CT, Nov. 20.(MEDICAL DEVICES): An article from: Warning Letter Bulletin
Unavailable
9.95
View Details ›
DOE factors into bioassay development, says USP workshop.(Design of Experiments): An article from: Validation Times
Carrie Nathans
9.95
View Details ›
FDA questions process validity at Contract Medical Manufacturing.(Medical Devices): An article from: Validation Times
Rebecca Mashaw
9.95
View Details ›
Teva slammed with 16 GMP observations after audit of parenteral facility.(Human Drugs): An article from: Validation Times
Rebecca Mashaw
9.95
View Details ›
Wallach receives 10-item 483 for device design, process control issues.(MEDICAL DEVICES): An article from: Inspection Monitor
Unavailable
9.95
View Details ›
Medi-Stat cited for failure to conduct identity tests.(Human drugs): An article from: Validation Times
Rebecca Mashaw
9.95
View Details ›
Medical & Clinical Consortium slapped with 16-item 483.(Medical Devices): An article from: Validation Times
Rebecca Mashaw
9.95
View Details ›
Wyeth vaccine facility faulted for quality, production and laboratory system controls.(Biologics): An article from: Validation Times
Rebecca Mashaw
9.95
View Details ›
CDER guidance for generics offers some help to OTC drug makers, but FDA may incorporate guidance in monographs.(Impurities): An article from: Validation Times
Melissa Winn
9.95
View Details ›
Pfizer given stern warning about PADE, PDMA compliance.(Human Drugs): An article from: Validation Times
Unavailable
9.95
View Details ›
Documentation failures at GE Healthcare IITS.(Medical Devices): An article from: Validation Times
Rebecca Mashaw
9.95
View Details ›
Inspectors focus on process design and implementation under ICH guidelines.: An article from: Inspection Monitor
Melissa A. Winn
9.95
View Details ›
FDA uses more than lab analysis of APIs to find fake drugs; excipient variation a major clue.(Counterfeiting): An article from: Validation Times
Tara Y. Coyt
9.95
View Details ›
Organizations on both sides of the Atlantic address issues related to excipients.(Excipients): An article from: Validation Times
Liz Swain
9.95
View Details ›
Cambrex warned about GMP violations at facility: Aug. 12-Milano, Italy.(Human Drugs): An article from: Validation Times
Rebecca Mashaw
9.95
View Details ›
Makers of non-actives to focus on quality systems, transparency and traceability.(Excipients): An article from: Validation Times
Carrie Nathans
9.95
View Details ›
Validation, documentation problems found at Contract Medical Manufacturing.(Medical Devices): An article from: Validation Times
Rebecca Mashaw
9.95
View Details ›
Contract Pharmacal warned about manufacturing drugs without approved applications.(Human Drags): An article from: Validation Times
Unavailable
9.95
View Details ›
Teva slammed with 16 observations after audit of parenteral facility.(HUMAN DRUGS): An article from: Inspection Monitor
Unavailable
9.95
View Details ›
PMT Corp. Chanhassen, MN, Dec. 3 Minneapolis District.(MEDICAL DEVICES): An article from: Warning Letter Bulletin
Unavailable
9.95
View Details ›
PMT failed to validate processes, FDA says in letter: Minneapolis District--Dec. 3.(Medical Devices): An article from: Validation Times
Rebecca Mashaw
9.95
View Details ›
Inspection log.: An article from: Inspection Monitor
Unavailable
9.95
View Details ›
Stericon Pharma warned about GMP significant violations of GMP regs.(Human Drugs): An article from: Validation Times
Unavailable
9.95
View Details ›
Amerifit Pharma slapped with 26-item 483 for failure to follow procedures.(HUMAN DRUGS): An article from: Inspection Monitor
Unavailable
9.95
View Details ›
OTC drug maker cited for failure to investigate deviations, provide GMP training.(HUMAN DRUGS): An article from: Inspection Monitor
Unavailable
9.95
View Details ›
FDA to start enforcing labeling requirements for OTC drug products Sept. 30.(Labeling): An article from: Validation Times
Melissa A. Winn
9.95
View Details ›
McNeil plant that produced recalled children's OTC drugs cited for 20 observations in April inspection.(HUMAN DRUGS): An article from: Inspection Monitor
Unavailable
9.95
View Details ›
McNeil plant that produced recalled children's OTC drugs cited for 20 observations in April inspection.(Human Drugs): An article from: Validation Times
Rebecca Marshaw
9.95
View Details ›
1
2
Next →
